Aclaris Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BML CAPITAL MANAGEMENT, LLC | 02/03/2026 | 14.25 M | $42.89 M | 0.00% | 11.62% |
| VIVO CAPITAL, LLC | 02/13/2026 | 8.89 M | $26.76 M | 0.00% | 7.25% |
| BLACKROCK, INC. | 02/12/2026 | 6.80 M | $20.48 M | 19.56% | 5.55% |
| VANGUARD GROUP INC | 01/29/2026 | 6.50 M | $19.57 M | -0.21% | 5.30% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 4.45 M | $13.41 M | -3.38% | 3.63% |
| DECHENG CAPITAL LLC | 02/12/2026 | 4.04 M | $12.17 M | 0.00% | 3.30% |
| MORGAN STANLEY | 02/13/2026 | 3.42 M | $10.28 M | -16.23% | 2.79% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 3.37 M | $10.15 M | -36.13% | 2.75% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.39 M | $7.20 M | 0.14% | 1.95% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 2.12 M | $6.39 M | -8.79% | 1.73% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 2.10 M | $6.31 M | -11.65% | 1.71% |
| KOTLER KEVIN | 02/17/2026 | 1.71 M | $5.13 M | 100.00% | 1.39% |
| PALO ALTO INVESTORS LP | 02/17/2026 | 1.57 M | $4.72 M | 0.00% | 1.28% |
| STATE STREET CORP | 02/13/2026 | 1.51 M | $4.53 M | 35.33% | 1.23% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 1.43 M | $4.32 M | 34.33% | 1.17% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.21 M | $3.63 M | -15.87% | 0.98% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.14 M | $3.43 M | 100.00% | 0.93% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 1.13 M | $3.39 M | -30.52% | 0.92% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 1.05 M | $3.17 M | -32.24% | 0.86% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 987.35 K | $2.97 M | 6.94% | 0.81% |
| ALDEBARAN CAPITAL, LLC | 02/12/2026 | 954.26 K | $2.87 M | -3.39% | 0.78% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 916.85 K | $2.76 M | 2,430.14% | 0.75% |
| BOLLARD GROUP LLC | 02/13/2026 | 804.45 K | $2.42 M | -34.36% | 0.66% |
| WOODLINE PARTNERS LP | 02/17/2026 | 742.01 K | $2.23 M | 100.00% | 0.61% |
| THREE BRIDGE WEALTH ADVISORS, LLC | 02/10/2026 | 714.82 K | $2.15 M | 0.00% | 0.58% |
| NORTHERN TRUST CORP | 02/17/2026 | 664.26 K | $2.00 M | -5.22% | 0.54% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 632.50 K | $1.90 M | -33.84% | 0.52% |
| JPMORGAN CHASE & CO | 02/11/2026 | 625.96 K | $1.88 M | -17.48% | 0.51% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 613.99 K | $1.85 M | 64.31% | 0.50% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 600.00 K | $1.81 M | -60.00% | 0.49% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 574.21 K | $1.73 M | 55.99% | 0.47% |
| MARSHALL WACE, LLP | 02/13/2026 | 485.50 K | $1.46 M | -71.74% | 0.40% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 447.18 K | $1.35 M | -17.91% | 0.36% |
| AISLING CAPITAL MANAGEMENT LP | 02/10/2026 | 434.46 K | $1.31 M | 0.00% | 0.35% |
| UBS GROUP AG | 01/29/2026 | 362.54 K | $1.09 M | 244.82% | 0.30% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 330.02 K | $993.36 K | -16.09% | 0.27% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 318.43 K | $958.46 K | -75.08% | 0.26% |
| HIGHTOWER ADVISORS, LLC | 02/06/2026 | 305.95 K | $920.90 K | -1.09% | 0.25% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 284.60 K | $856.66 K | 17.63% | 0.23% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 270.85 K | $814.64 K | 64.91% | 0.22% |
| RAYMOND JAMES FINANCIAL INC | 02/18/2026 | 269.68 K | $811.75 K | -4.87% | 0.22% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 264.36 K | $795.72 K | 100.00% | 0.22% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 255.40 K | $768.75 K | -27.05% | 0.21% |
| NUVEEN, LLC | 02/12/2026 | 237.83 K | $715.87 K | 0.00% | 0.19% |
| INVESCO LTD. | 02/19/2026 | 209.90 K | $631.81 K | 29.20% | 0.17% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 203.52 K | $612.59 K | -7.53% | 0.17% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 154.55 K | $465.21 K | 0.00% | 0.13% |
| BARCLAYS PLC | 02/13/2026 | 143.41 K | $431.68 K | 16.20% | 0.12% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 140.17 K | $422.00 K | 0.00% | 0.11% |
| XTX TOPCO LTD | 02/17/2026 | 112.91 K | $339.87 K | 76.63% | 0.09% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aclaris Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 164 institutional investors and hedge funds held shares of Aclaris Therapeutics Inc. The most heavily invested institutionals were:
BML Capital Management, LLC: 14.25 M
Connor, Clark & Lunn Investment Management Ltd.: 1.42 M
DEUTSCHE BANK AG\: 997,850
Aldebaran Capital, LLC: 947,162
Three Bridge Wealth Advisors, LLC: 714,823
VANGUARD FIDUCIARY TRUST CO: 628,859
68.29% of Aclaris Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 91.93 M shares in the last 24 months. This purchase volume represents approximately $311.66 M in transactions.